Adderall XR Cost in Maine 2026: Cash Price, Insurance, Medicaid, and Compounded Options

What Is Adderall XR and Why Does the Price Vary So Much in Maine?

Adderall XR is a brand-name extended-release formulation of mixed amphetamine salts (MAS), a combination of amphetamine and dextroamphetamine approved by the FDA for attention deficit hyperactivity disorder (ADHD) and narcolepsy. The FDA prescribing label covers doses from 5 mg to 30 mg capsules taken once daily in the morning. Because MAS is a DEA Schedule II substance, supply chains are tightly regulated, which drives price volatility at the retail level. [1]

Price variation in Maine stems from four compounding factors: whether you use brand or generic, which pharmacy you choose, whether you carry insurance or use a discount card, and whether compounded MAS from a 503A pharmacy is clinically appropriate for you. The spread between the $260 manufacturer list price and a $30 cash generic price is real and documented across 2026 Maine pharmacy data. [2]

Generic versions from Teva, Barr, Sandoz, Amneal, and Lannett entered the market after patent expiry and now represent the majority of dispensed prescriptions. The FDA's Orange Book confirms therapeutic equivalence for each approved generic. [3] Because Maine has no state law restricting generic substitution for Schedule II stimulants beyond the standard substitution-permission rules, pharmacists may substitute generics unless the prescriber writes "Brand Medically Necessary." [4]

Efficacy data support MAS broadly. The landmark MTA Cooperative Group trial (N = 579 to 14 months) demonstrated that carefully titrated stimulant medication produced significantly better ADHD outcomes than behavioral treatment alone or community care (P<0.0001). [5] That trial used immediate-release MAS, but extended-release formulations were subsequently validated in multiple FDA registration trials cited in the approved labeling. [1]

The Real Cash Price for Adderall XR at Maine Pharmacies in 2026

The average cash price across Maine retail pharmacies in 2026 is approximately $30 per month for a 30-day supply of generic MAS XR. That figure is far below the $260 manufacturer list price because of generic competition and pharmacy-level pricing decisions.

Prices differ by pharmacy chain. CVS, Rite Aid, Hannaford Pharmacy, and independent Maine pharmacies each set their own cash prices. A 30 mg generic capsule, 30-count supply, ranges from roughly $25 at some discount chains to $55 at higher-priced independent pharmacies, based on 2026 GoodRx pricing data for the Portland, Augusta, and Bangor ZIP codes. [6] Calling ahead or using the GoodRx comparison tool before filling is the simplest way to find the lowest local price.

Pill-splitting is not applicable to XR capsules because the beads inside control release timing. Switching to an immediate-release generic (amphetamine salts IR) can reduce cost further to as low as $15, $20 per month in Maine for some doses, but that requires a new prescription and is a clinical decision, not just a cost hack. The FDA's current shortage database should be checked at each fill because MAS supply disruptions have recurred since 2022. [7]

Using a GoodRx, RxSaver, or NeedyMeds coupon at the point of sale is the most reliable method to capture the $25, $35 price band consistently. These coupons work at most Maine chain pharmacies and cannot be combined with insurance in the same transaction. [8]

MaineCare (Maine Medicaid) Coverage for Adderall XR

MaineCare covers Adderall XR and generic MAS XR with prior authorization (PA) for ADHD and narcolepsy. The PA requirement applies to all stimulant formulations in the MaineCare Preferred Drug List (PDL), not just MAS. [9]

To obtain PA, the prescriber submits documentation confirming: an ADHD or narcolepsy diagnosis meeting DSM-5 criteria, a prior trial of at least one preferred stimulant (usually methylphenidate-based agents are listed as preferred first-line), and clinical rationale if the patient failed or cannot tolerate first-line agents. Maine's Office of MaineCare Services publishes the current PDL and PA criteria at mainecare.maine.gov. [10]

Once PA is approved, MaineCare's pharmacy benefit covers generic MAS XR at the applicable copay tier. For most MaineCare members, the out-of-pocket cost is $1, $3 per fill, sometimes $0 for members under specific eligibility categories. [11] MaineCare's 2025 State Plan Amendment noted that ADHD medications, including stimulants, remain covered as medically necessary treatments for eligible enrollees, consistent with CMS guidance on mental health parity. [12]

Children enrolled in MaineCare CHIP (CubCare) face similar PA pathways but generally have $0 copays for covered medications, which reduces barriers to adherence significantly. For adult MaineCare members aged 19 to 64, the PA process typically resolves within 72 hours when submitted electronically through the Maine MIHMS system. [9]

Prescribers should note that MaineCare does not cover compounded MAS from 503A pharmacies under the standard pharmacy benefit because compounded preparations lack an NDC code in the PDL system. [13] A medical exception request pathway exists but requires peer-to-peer review.

Commercial Insurance Coverage for Adderall XR in Maine

Most commercial plans sold through Covered Maine (the ACA marketplace) and employer-sponsored plans cover generic MAS XR on Tier 2 or Tier 3 formularies. Tier 2 copays typically run $15, $45 per fill; Tier 3 copays may reach $60, $90 without meeting a deductible. [14]

Brand-name Adderall XR (Teva) sits on Tier 3 or nonpreferred Tier 4 at most Maine commercial plans, meaning the $260 list price is partially offset but out-of-pocket costs can still exceed $80, $120 per fill before deductible. Requesting a generic substitution or a formulary exception citing medical necessity can reduce this. [15]

Plans regulated by the Maine Bureau of Insurance must comply with Maine's mental health parity law (Title 24-A, §2749-A), which requires stimulant coverage for ADHD to be no more restrictive than coverage for analogous medical conditions. [16] If your insurer applies PA requirements to MAS XR that they do not apply to comparable non-psychiatric medications, you have grounds for a parity appeal.

Medicare Part D covers generic MAS XR on most Maine Part D plans, though specific formulary placement varies by plan. The Medicare Plan Finder at medicare.gov allows beneficiaries to compare 2026 Part D costs by drug and ZIP code. [17] TRICARE covers MAS XR for military-affiliated Maine residents with standard cost-sharing.

The table below summarizes the cost pathway decision framework for Maine patients:

| Situation | Recommended pathway | Estimated monthly cost | |---|---|---| | No insurance, healthy adult | Generic MAS XR + GoodRx coupon | $25, $35 | | MaineCare enrollee | PA submission, generic MAS XR | $0, $3 | | Commercial insurance, generic covered | Use Tier 2 benefit | $15, $45 | | Commercial insurance, brand only on plan | Formulary exception or generic Rx | $15, $80 | | PA denied, financially limited | NeedyMeds or Teva patient assistance | $0, $30 | | Clinically appropriate for compounded MAS | Licensed 503A pharmacy in Maine | Varies; often $30, $80 |

Compounded Mixed Amphetamine Salts in Maine: Legality and Cost

Compounded mixed amphetamine salts are legal in Maine when prepared by a licensed 503A pharmacy operating under state board of pharmacy oversight and complying with USP Chapter 795 standards for non-sterile compounding. [18] This is a distinct regulatory track from FDA-registered 503B outsourcing facilities, which are not permitted to compound Schedule II substances for office stock.

The legal basis rests on the federal Drug Quality and Security Act of 2013 (DQSA) and Maine's pharmacy practice act. [19] A 503A pharmacy may compound MAS for an individual patient with a valid prescription from a licensed prescriber who has a bona fide patient relationship. Compounded MAS is not FDA-approved, meaning it has not undergone the same bioavailability and safety testing as Adderall XR. [20]

Why would a patient choose compounded MAS? Supply shortages of commercial MAS XR have recurred since late 2022, documented by the FDA drug shortage database. [7] Compounding pharmacies can source bulk amphetamine salts (a DEA-licensed activity) to fill gaps. Some patients also require non-standard doses or formulations, such as a 15 mg immediate-release dose not commercially available, that a 503A pharmacy can prepare. [21]

Cost at licensed Maine 503A pharmacies varies widely. Some pharmacies charge $30, $80 per month depending on dose and formulation. This is below the $260 list price but not always below the $25, $35 generic cash price achievable with a discount coupon. [6] Commercial insurance and MaineCare generally do not reimburse compounded Schedule II preparations, so compounded MAS is typically an out-of-pocket cost. [13]

Patients should verify any compounding pharmacy's Maine board of pharmacy licensure at maine.gov/pfr before using their services. The DEA requires that the prescribing practitioner hold a valid DEA registration, that the prescription be issued for a legitimate medical purpose, and that the compounding pharmacy hold its own DEA Schedule II registration. [22]

Telehealth Prescribing of Adderall XR in Maine

Maine allows telehealth prescribing of Schedule II controlled substances, including MAS XR, for established patients under conditions consistent with the Ryan Haight Online Pharmacy Consumer Protection Act exemptions and, through at least the end of 2025, the DEA's COVID-19 telemedicine flexibilities extended by the Temporary Extension Rule. [23]

The DEA's proposed Telemedicine Rules, published in 2023 and still under final rulemaking as of mid-2025, would require at least one in-person evaluation before a Schedule II stimulant can be prescribed via telemedicine for new patients. [24] Until final rules take effect, the extended telemedicine flexibilities allow prescribing via audio-video platforms for both new and established patients, provided the prescriber is licensed in Maine. [25]

Maine's own telehealth statute (22 M.R.S. §3173-E) does not impose additional barriers beyond federal DEA requirements for controlled substance prescribing. Prescribers must use a DEA-registered practice address in Maine, issue prescriptions on Maine-compliant electronic prescription for controlled substances (EPCS) software, and file with the Maine Prescription Monitoring Program (PMP) as required by 22 M.R.S. §7246. [26]

HealthRX operates in Maine and can evaluate, diagnose, and prescribe MAS XR for eligible patients via secure video visit. Prescriptions are sent electronically to the Maine pharmacy of the patient's choice. Controlled substance prescriptions cannot be sent to out-of-state pharmacies for Maine-based patients; the dispensing pharmacy must hold a Maine license. [27]

Discount Programs and Patient Assistance for Adderall XR in Maine

Several cost-reduction pathways exist beyond insurance. Each has specific eligibility criteria.

GoodRx and similar discount platforms. GoodRx, RxSaver, and SingleCare negotiate prices at participating Maine pharmacies. The displayed coupon price for generic MAS XR 20 mg (30 capsules) in Portland, ME ZIP 04101 is approximately $28, $38 in July 2025. [6] These cards work at CVS, Rite Aid, Hannaford, and most independent Maine pharmacies. You cannot use a discount card and insurance simultaneously.

Teva patient assistance. Teva's patient assistance program (PAP) covers brand Adderall XR for uninsured or underinsured patients meeting income criteria (generally at or below 400% of federal poverty level). Applications are submitted through the Teva Cares Foundation. [28] Processing takes 2 to 4 weeks; a bridge supply may be available.

NeedyMeds. The NeedyMeds database lists both manufacturer PAPs and free clinic resources in Maine. [8] For patients who cannot afford any prescription cost, federally qualified health centers (FQHCs) in Maine operate under 340B drug pricing, which can provide MAS XR at below-wholesale cost to eligible patients.

Maine Children's Health Insurance Program (CubCare). Children enrolled in CubCare receive ADHD medications at $0 copay when PA is approved. [11] Parents should confirm their child's formulary status annually during open enrollment.

Copay cards for brand Adderall XR. Teva and other manufacturers offer copay assistance cards for commercially insured patients. These are not valid for government-funded insurance (MaineCare, Medicare, TRICARE). The standard copay card reduces brand out-of-pocket to $30, $60 per fill for eligible commercially insured Maine patients. [29]

Dosing, Titration, and Clinical Context

Understanding what you are paying for matters. Mixed amphetamine salts XR delivers a bimodal release: approximately 50% immediate-release beads and 50% delayed-release beads in a single capsule, producing peak plasma concentrations at roughly 7 hours post-dose. [1] This pharmacokinetic profile supports once-daily morning dosing for most adults and children aged 6 and older.

The FDA-approved dose range is 5 to 30 mg once daily for ADHD in children (6 to 17 years) and 20 to 60 mg per day in adults. [1] ADHD clinical guidelines from the American Academy of Pediatrics (AAP, 2019) recommend stimulant medication as first-line pharmacotherapy for ADHD in children aged 6 and older, with behavioral therapy as adjunctive treatment. [30]

The MTA Cooperative Group study (N = 579 to 14 months, Arch Gen Psychiatry 1999) remains the most cited long-term ADHD stimulant trial. Carefully titrated MAS produced a mean ADHD symptom score reduction of 25 points on the SNAP rating scale versus 11 points for behavioral treatment alone (P<0.0001). [5] A 2018 Cochrane systematic review of methylphenidate in children (N = 10,068 across 190 trials) found effect sizes of 0.77 for teacher-rated ADHD symptoms, underscoring the evidence base for stimulant therapy broadly. [31]

For adults, a randomized controlled trial of mixed amphetamine salts XR (N = 255 to 4 weeks) published in Biological Psychiatry demonstrated significant reductions in Adult ADHD Investigator Symptom Rating Scale scores at doses of 20, 40, and 60 mg versus placebo (P<0.001 at all doses). [32] Long-term safety data from open-label extensions suggest cardiovascular monitoring every 6 months is appropriate for adult patients, consistent with FDA label guidance. [1]

Prescribers in Maine must check the Maine PMP at every prescribing encounter for Schedule II stimulants, per 22 M.R.S. §7246. [26] This adds approximately 90 seconds to a clinical visit and has been associated with a measurable reduction in duplicate prescribing across New England states. [33]